Updated 5/26/2021 3:58 PM
The Elijah E. Cummings Lower Drug Costs Now Act purports to set requirements and establish programs to, among other things, regulate the prices of prescription drugs, health care costs, and insurance coverage.
Under HR3, the United States Department of Health and Human Services would then be in charge of negotiating the prices for certain drugs.
Concerns can be raised that governmental agencies or politicians may be acting with the intent of furthering their own agendas rather than in the best interests of the people.
The government does not need to start dictating the prices of medications or adding regulations; what is needed is for the government to enact policies that advance new medical developments -- especially in the middle of a global pandemic. America is a leading innovator in medicine and in the pharmaceutical industry, and the future of cutting edge medicines and treatments is at stake.